James D Arecca is Chief Financial Officer of TherapeuticsMD, Inc.. Currently has a direct ownership of 123,830 shares of TXMD, which is worth approximately $134,974. The most recent transaction as insider was on Aug 12, 2021, when has been sold 93,337 shares (Common Stock) at a price of $0.87 per share, resulting in proceeds of $81,203. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 124K
0% 3M change
0% 12M change
Total Value Held $134,974

James DArecca Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 12 2021
SELL
Open market or private sale
$81,203 $0.87 p/Share
93,337 Reduced 42.98%
123,830 Common Stock
Aug 10 2021
BUY
Exercise of conversion of derivative security
-
217,167 Added 50.0%
217,167 Common Stock

Also insider at

HAE
HAEMONETICS CORP Healthcare
PBH
Prestige Consumer Healthcare Inc. Healthcare
JD

James D Arecca

Chief Financial Officer
Boca Raton, FL

Track Institutional and Insider Activities on TXMD

Follow TherapeuticsMD, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TXMD shares.

Notify only if

Insider Trading

Get notified when an Therapeutics Md, Inc. insider buys or sells TXMD shares.

Notify only if

News

Receive news related to TherapeuticsMD, Inc.

Track Activities on TXMD